Furthermore, Espinoza et al. also described Claudin-18 (CLDN-18) as a membrane marker of gallbladder metaplasia within the progression sequence towards GBC, where the CLDN-18 expression is also present in ~50% of gallbladder tumors [78]. The gene discussed is CLDN18; the disease is gallbladder neoplasm.